Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.

Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...

It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...

Gadgets, services, and technologies work in science fiction because it is fiction. In fiction, it is very easy to make things ...